Downregulation of Mir-31, Mir-155, and Mir-564 in Chronic Myeloid Leukemia Cells

• Oshrat Hershkovitz Rokah ,

  Contributed equally to this work with: Oshrat Hershkovitz Rokah, Galit Granot

  Affiliation Felsenstein Medical Research Center, Beilinson Hospital, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

  ⨯
• Galit Granot ,

  Contributed equally to this work with: Oshrat Hershkovitz Rokah, Galit Granot

  * E-mail: galitg@clalit.org.il

  Affiliation Felsenstein Medical Research Center, Beilinson Hospital, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

  ⨯
• Adelina Ovcharenko,

  Affiliation Felsenstein Medical Research Center, Beilinson Hospital, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

  ⨯
• Shira Modai,

  Affiliation Department of Cell and Developmental Biology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

  ⨯
• Metsada Pasmanik-Chor,

  Affiliation Bioinformatics Unit, Faculty of Life Sciences, Tel Aviv University, Tel Aviv, Israel

  ⨯
• Amos Toren,

  Affiliation Department of Pediatric Hematology-Oncology, Safra Children's Hospital, Tel-Hashomer, Israel

  ⨯
• Noam Shomron,

  Affiliation Department of Cell and Developmental Biology, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

  ⨯
• Ofer Shpilberg

  Affiliations Felsenstein Medical Research Center, Beilinson Hospital, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel, Institute of Hematology, Beilinson Hospital, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel

  ⨯